Changes in sRAGE levels in BALF after 120 consecutive days of CS exposure. حسب Yue He (385239)

الموضوعات:

Pathological changes in lung tissue of mice exposed to continuous inhalation of CS. حسب Yue He (385239)

الموضوعات:

Changes in inflammatory cell count in BALF of mice exposed to continuous CS inhalation. حسب Yue He (385239)

الموضوعات:

Correlation between sRAGE levels and pulmonary dysfunction and inflammatory response in CS exposed 120 day group mice. حسب Yue He (385239)

الموضوعات:

Changes in the expression of inflammatory cytokines in BALF of mice exposed to continuous CS inhalation. حسب Yue He (385239)

الموضوعات:

Comparison of body weight gain between control group and cigarette smoke exposed group mice. حسب Yue He (385239)

الموضوعات:

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

GLS inhibition decreases IL-1β secretion <i>in vitro</i>. حسب Bárbara Ponzilacqua-Silva (17002156)

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. حسب Wenbin Wu (292223)

الموضوعات:

The resistivity at a depth of 18cm at different time points under unsaturated conditions varies with depth. حسب Kui Suo (20614613)

الموضوعات:

Consecutive time points of data collection. حسب Martin Matzka (2636344)

"…Effect sizes expectedly decreased over time. Physical quality of life remained relatively constant over time and was the only outcome for which social integration on admission was not a significant prognostic factor.…"

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... حسب Anneli Peolsson (7867601)

الموضوعات:

Selection of soil particle sampling points. حسب Xueting Ma (390540)

الموضوعات:

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

The ANCOVA and Post_hoc results. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

The demographical and clinical characteristics of subjects at baseline. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

CONSORT flowchart. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Time to stabilization in the mediolateral direction. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Participant’s data including characteristics and primary outcome measurement. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Time to stabilization in the vertical direction. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات: